Virginia Commonwealth University

VCU Massey Cancer Center

Five tips for maintaining a healthy weight

According to the American Cancer Society (ACS), more than half of all cancer deaths could be prevented by making healthy choices like not smoking, maintaining a healthy weight, eating nutritiously and staying physically active. As January marks the start of new beginnings, here are five tips to help you keep your healthy weight resolutions this year. 

Continue reading →

Multiple sclerosis drug may one day treat colorectal cancer

Sarah Spiegel

After uncovering a mechanism that promotes chronic intestinal inflammation and the development of colorectal cancer, scientists from Virginia Commonwealth University Massey Cancer Center have found that fingolimod, a drug currently approved for the treatment of multiple sclerosis, could potentially eliminate or reduce the progression of colitis-associated cancer (CAC).

Continue reading →

Scientists discover how deadly skin cancer spreads into other parts of the body

Paul Fisher at his desk.

After recently announcing success in eliminating melanoma metastasis in laboratory experiments, scientists at Virginia Commonwealth University Massey Cancer Center have made another important discovery in understanding the process by which the gene mda-9/syntenin contributes to metastasis in melanoma (the spread of skin cancer) and possibly a variety of other cancers.

Continue reading →

Viagra drug trio improves effectiveness of cancer treatment while protecting the heart

A new drug combination featuring the widely-known impotence drug Viagra has been found to improve the effectiveness of cancer treatment while protecting the heart from harm caused by a popular form of chemotherapy. With nearly half of all cancer survivors dying from other conditions than cancer, most notably cardiovascular disease, this new treatment is not only innovative but necessary.

Continue reading →

Scientists discover mechanism that could reverse obesity

Massey research member Andrew Larner

Approximately 68 percent of U.S. adults are overweight or obese, according to the National Cancer Institute, which puts them at greater risk for developing cancer, cardiovascular disease, diabetes and a host of other chronic illnesses.  But an international team of scientists led by Virginia Commonwealth University Massey Cancer Center researcher Andrew Larner, M.D., Ph.D., has successfully reversed obesity in mice by manipulating the production of an enzyme known as tyrosine-protein kinase-2 (Tyk2). 

Continue reading →